Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹-856 Cr₹-288 Cr₹122 Cr₹122 Cr₹128 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA is ₹-856 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹-856 Cr
Mar2023₹-288 Cr
Mar2022₹122 Cr
Mar2021₹122 Cr
Mar2020₹128 Cr

How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹-856 Cr
Negative
Mar2023 ₹-288 Cr
Negative
Mar2022 ₹122 Cr
0.40
Mar2021 ₹122 Cr
-5.14
Mar2020 ₹128 Cr -

Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,294.4 Cr 0.1% 9.5% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,306.0 Cr -2.5% 7.6% 4.7% Stock Analytics
DIVIS LABORATORIES ₹150,343.0 Cr -3% 3.4% 61.5% Stock Analytics
CIPLA ₹117,323.0 Cr -1.6% 3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,619.0 Cr -0.3% 9% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,941.5 Cr -1.2% 2.9% -6.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.1%

9.5%

4.2%

SENSEX

-1.8%

2.7%

5%


You may also like the below Video Courses